European Information Network - Ethics in Medicine and Biotechnology
A project of the European Commission,Quality of Life and Management of Living Resources Programme
|
|
European Information Network - Ethics in Medicine and BiotechnologyA project of the European Commission,Quality of Life and Management of Living Resources Programme |
| Eureth.net Home | News | Events | Literature | Partners | Topics | Links | ENDEBIT | EUROETHICS | Thesaurus |
| DRZEs Eurethnet-Home | Contact us |
If you require further information, please contact the organizers directly.
| Back to calendar |
|
| Date: | 25.02.2004 to 27.02.2004 |
| Location: | Sheraton San Diego Hotel & Marina, 1380 Harbor Island Drive, San Diego, CA 92101, USA San Diego, CA USA |
| Details: | With the recent FDA approvals of Humira?, Xolair® and Bexxar®, there are currently 15 recombinant antibodies in the market, and several more are in the advanced stages of clinical development. Some analysts predict that one drug alone, Genentech's Avastin?, could generate as much as $2 billion in revenue when approved for treatment of colon cancer. IBC's 12th International Conference on Antibody Production and Downstream Processing, February 25-27, 2004, includes updates on all of the leading antibody-based therapeutics. With inside information from leading industry experts that can help you advance your antibody therapeutic program, this is the one event that scientists and executives consider a "must-attend." |
| Organizer: | ibc Life Sciences , USA |
| Contact: | Address: Customer Service, IBC USA Conferences, Inc., One Research Drive, Suite 400A, Westborough, MA 01581, USA Tel: +1 - 508 - 6 16 55 50 Fax: +1 - 508 - 6 16 55 22 Email: custserv@ibcusa.com |
| Webpage: | http://www.lifesciencesinfo.com/antibodyprod |
| Eureth.net Home | News | Events | Literature | Partners | Topics | Links | ENDEBIT | EUROETHICS | Thesaurus |
| EURETHNET site at © DRZE: last update 21.05.2008 General information | Administration: webmaster@drze.de |